
مقالات ISI ایمونوتراپی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.

Keywords: ایمونوتراپی; Mitoxantrone; Vaccination; Immunogenic cell death; Colon cancer; Liver metastases; T cells; Immunotherapy; Tumor-infiltrating lymphocytes;

Keywords: ایمونوتراپی; drug reaction; gp100; granuloma; granulomatous reaction; immunotherapy; interleukin-2; melanoma; melanoma-associated antigen 3; resiquimod; IL-2; interleukin-2 (); MAGE-3; melanoma-associated antigen 3 ();

Keywords: ایمونوتراپی; Immunotherapy; Lynch syndrome; Mismatch repair; PD-1 inhibitors;

Keywords: ایمونوتراپی; Immunotherapy; Tumor infiltrating lymphocytes; Antigen; Immune checkpoint inhibitor; Vaccine; Type I T-cells;

Keywords: ایمونوتراپی; Immunotherapy; Programmed cell death 1 receptor; Programmed cell death 1 ligand; Reinduction; Long-term follow-up;

Keywords: ایمونوتراپی; Allergic conjunctivitis; Immunotherapy; Oral tolerance; Pollen; Transgenic rice;

Keywords: ایمونوتراپی; Sarcoma; Immunotherapy; Epigenetics; Mutational burden; Chemoresistance;

Keywords: ایمونوتراپی; Anaphylaxis; immunotherapy; peanut allergy; pediatrics;

Keywords: ایمونوتراپی; BM; brain metastasis; AE; adverse event; CI; confidence interval; CTLA4; cytotoxic T-lymphocyte antigen-4; CT; computed-tomography; GPA; Graded Prognostic Assessment score; IORR; intracerebral objective response rate; IQR; interquartile range; NSCLC; nonâ

Keywords: ایمونوتراپی; Multiple primary tumors; Next-generation sequencing; Tumor mutational burden; Immunotherapy;

Keywords: ایمونوتراپی; AE; autoimmune epilepsy; AED; antiepileptic drug; IMT; immunotherapy; CBZ; carbamazepine; LCM; lacosamide; LTG; lamotrigine; LEV; levetiracetam; OXZ; oxcarbazepine; PHT; phenytoin; Autoimmune epilepsy;

Keywords: ایمونوتراپی; Bladder cancer; Immunotherapy; Prostate cancer; Renal cancer; Telomerases;

Keywords: ایمونوتراپی; Pancreatic cancer; Immunotherapy; Dendritic cells;

Keywords: ایمونوتراپی; Bladder cancer; Cost-effectiveness; Immunotherapy; Programmed death 1 receptor; Transitional cell carcinoma;

Keywords: ایمونوتراپی; TKI; Angiogenesis; Immune system; Renal carcinoma; Immunotherapy;

Keywords: ایمونوتراپی; Anti-PD-1/PD-L1; Immunotherapy; Immune checkpoint inhibitors; mRCC; Targeted therapies;

Keywords: ایمونوتراپی; Urothelial carcinoma; Bladder cancer; Immunotherapy; Checkpoint inhibitors; Chemotherapy; Clinical trials; Targeted therapy; Platinum ineligible;

Keywords: ایمونوتراپی; Immunotherapy; Organ transplant; Allograft; Immune checkpoint; Checkpoint inhibitor;

Keywords: ایمونوتراپی; Atezolizumab; Immunotherapy; Number of prior regimens; Previous platinum-based chemotherapy; Urothelial carcinoma;

Keywords: ایمونوتراپی; Angiogenesis; cancer; cancer stem-cell; check-point; immunotherapy; inflammation; metastasis; oncogene; tumour-suppressor gene;

Keywords: ایمونوتراپی; Bayesian Markov model; Cost-effectiveness; First-line therapy; Immunotherapy; NSCLC; Pembrolizumab;

Keywords: ایمونوتراپی; Colorectal cancer; Cytokines; Immune response; Immunotherapy; Inflammation; Anatomical subsite heterogeneity; CIMP; CpG island methylator phenotype; CIN; chromosomal instability; CRC; colorectal cancer; FGF-2; fibroblast growth factor 2 (basic); G-CSF; gr

Keywords: ایمونوتراپی; Atezolizumab; Expanded access program; Immunotherapy; Urothelial carcinoma;

Keywords: ایمونوتراپی; Sarcomatoid renal cell carcinoma; Renal cell carcinoma; Nephrectomy; Chemotherapy; Targeted therapy; Immunotherapy;

Keywords: ایمونوتراپی; Lung cancer; Latin America; Immunotherapy; Targeted therapy; Healthcare access;

Keywords: ایمونوتراپی; Immunotherapy; Combination therapy; Review; Triple negative breast cancer;

Keywords: ایمونوتراپی; Cost Effectiveness; Everolimus; Immunotherapy; Programmed death 1 receptor; Renal cell carcinoma;

Keywords: ایمونوتراپی; Hepatocellular carcinoma; Systemic treatment; Immunotherapy; Tyrosine kinase inhibitor;

Keywords: ایمونوتراپی; Status epilepticus; Inflammatory CNS disease; Autoimmune encephalitis; Immunotherapy; Unknown/cryptogenic; CNS; central nervous system; SE; status epilepticus; ICU; intensive care unit; NORSE; new onset refractory status epilepticus; EEG; electroencephalo

Keywords: ایمونوتراپی; Moxibustion; Tuberculosis; HIV; MDR-TB; Immuno-modulation; Immunotherapy; Randomised control trial;

Keywords: ایمونوتراپی; Cancer; Immunotherapy; Checkpoint modulators; Cancer vaccines; Adoptive immunotherapy; CAR-T; Immune-related adverse events; Oncologic emergency;

Keywords: ایمونوتراپی; Glioblastoma; Immunotherapy; Adoptive transfer; Immunization; Passive; Cancer vaccines;

Keywords: ایمونوتراپی; Malignant pleural effusion; Intra-pleural bacterial products; Immunotherapy; Systematic review;

Keywords: ایمونوتراپی; Irinotecan; Oxaliplatin; 5-fluorouracil; Antiepidermal growth factor receptor antibody; Vascular endothelial growth factor antibody; Immunotherapy; Regorafenib; Trifluridine/tipiracil;

Keywords: ایمونوتراپی; Microwave ablation; Immune checkpoints blockade; Breast cancer; Immunotherapy; T-cell;

Keywords: ایمونوتراپی; VC; verrucous carcinoma; BSCC; basaloid squamous cell carcinoma; LEC; lymphoepithelial carcinoma; ASC; adenosquamous carcinoma; SCNC; small cell neuroendocrine carcinoma; LCNC; large cell neuroendocrine carcinoma; NUTMC; NUT midline carcinoma; RMS; rhabdo

Keywords: ایمونوتراپی; Adolescent and young adult; Acute lymphoblastic leukemia; Clinical trials; Immunotherapy; Salvage chemotherapy;

Keywords: ایمونوتراپی; Cancer; Transmissible venereal tumor; Tumor cell lysate; Dendritic cells; Immunotherapy;

Keywords: ایمونوتراپی; Melanoma brain metastasis; Radiation therapy; Stereotactic radiosurgery; SRS; Immunotherapy; NCDB;

Keywords: ایمونوتراپی; Immunotherapy; CAR-T; Cellular therapy; Toxicity;

Keywords: ایمونوتراپی; Alloantigen; Cyclophosphamide; Immunotherapy; Regulatory T cells; Tumor microenvironment;

Keywords: ایمونوتراپی; Adenosine; gastric cancer; A2aR signaling; immunotherapy;

Keywords: ایمونوتراپی; Allergen-specific IgE; Allergoid; Cat dander; Immunotherapy; Safety;

Keywords: ایمونوتراپی; cancer; immune-related adverse event; immunotherapy; primary care; toxicities;

Keywords: ایمونوتراپی; CAF; cancer-associated fibroblast; CRC; colorectal cancer; FAP; fibroblast activation protein; H&E; hematoxylin-and-eosin; HGP; histopathological growth pattern; LSEC; liver sinusoidal endothelial cells; OS; overall survival; VEGF; vascular endothelial gr

Keywords: ایمونوتراپی; Prostate cancer; kidney cancer; bladder cancer; chemotherapy; immunotherapy;

Keywords: ایمونوتراپی; EBV; Immunotherapy; PD-L1; Gastric cancer; Viruses; Biomarker;

Keywords: ایمونوتراپی; Animal models; Cancer microenvironment; Immuno-oncology; Immunotherapy; One Health;

Keywords: ایمونوتراپی; Atezolizumab; Chemotherapy; Immunotherapy; Non-small-cell lung cancer; Chemotherapy-immunotherapy combinations;

Keywords: ایمونوتراپی; Inflammation; Immunomodulation; Immunotherapy; Prevention; Immune mechanisms of cardiovascular disease; Ischemic heart disease;